Eusa Pharma
EUSA Pharma gets FDA green light to evaluate IL-6 inhibitor siltuximab in COVID-19 patients
July 2, 2020Research and Development COVID-19, Eusa Pharma, siltuximab
Efforts push on to discover an effective treatment for COVID-19 in more than 100 different drug candidates worldwide. EUSA Pharma …
EUSA Pharma’s COVID-19 drug improves or stabilises respiratory condition in 76% of patients
April 2, 2020Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, siltuximab
EUSA Pharma has unveiled promising preliminary findings from an interim analysis of siltuximab in the treatment of serious respiratory complications …
EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications
March 31, 2020Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma
Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …
EUSA Pharma bolsters senior leadership team with two appointments
May 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eusa Pharma, appointment
Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two …
EUSA Pharma acquires global rights to oncology support drug
April 12, 2016Manufacturing and Production, Research and Development, Sales and Marketing Eusa Pharma, acroral, acroral tab, global rights, oncology
EUSA Pharma has announced the acquisition of global rights to oncology support care product, Arcoral Tab, from Arcoral Pharma.
EUSA Pharma appoints chief executive and director
April 22, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bryan Morton, Eusa Pharma, Göran Ando, Lee Morley
Recently-established UK-based EUSA Pharma has confirmed the appointment of Lee Morley as its chief executive and Dr Göran Ando (pictured) …
Stephen Stamp joins board at Eusa Pharma
September 7, 2010Sales and Marketing Eusa Pharma, appointment, sales and marketing
Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director. Stephen has previously …
Eusa Pharma appoints Iain McGill
March 10, 2010Sales and Marketing Eusa Pharma, appointment, sales and marketing
Iain McGill has joined specialty company Eusa Pharma as international and European president. He moves to Eusa from Wyeth Pharmaceutical, …
